Evolución y salud: evolución experimental y epidemiología
EVOSALUD
Universidade da Coruña
La Coruña, EspañaPublicaciones en colaboración con investigadores/as de Universidade da Coruña (6)
2022
-
Essential Topics for the Regulatory Consideration of Phages as Clinically Valuable Therapeutic Agents: A Perspective from Spain
Microorganisms, Vol. 10, Núm. 4
-
Phenotypic and genomic comparison of klebsiella pneumoniae lytic phages: Vb_kpnm-vac66 and vb_kpnm-vac13
Viruses, Vol. 14, Núm. 1
-
The role of PemIK (PemK/PemI) type II TA system from Klebsiella pneumoniae clinical strains in lytic phage infection
Scientific Reports, Vol. 12, Núm. 1
2021
-
Enhanced antibacterial activity of repurposed mitomycin C and imipenem in combination with the lytic phage vB_KpnMVAC13 against clinical isolates of klebsiella pneumoniae
Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 9
2020
-
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure
Antiviral Research, Vol. 174
2019
-
Reporting identification of Acinetobacter spp genomic species: A nationwide proficiency study in Spain
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 2, pp. 89-92